On the Margins — 2026-03-03
On the Margins
Your daily health economics & actuarial brief
Tuesday, March 03, 2026
What's happening today
| ■ | Medicaid dental benefits in about three dozen states face disruption under a GOP plan targeting $900B in cuts. |
| ■ | RAND says states could absorb OBBBA's $664B Medicaid reductions through 2034, with varied budget tools and tradeoffs. |
| ■ | BCBS Massachusetts reported a $223M net loss for 2025 as medical and pharmacy trends accelerated. |
| ■ | GoodRx launched an employer GLP-1 buydown program that routes discounts outside the traditional pharmacy benefit. |
Key Stories
Medicaid dental coverage in three dozen states meets $900B cut threat
KFF Health News said Medicaid is paying for more dental care in more than three dozen states. It warned that roughly $900 billion in federal Medicaid funding cuts over the next decade could drive states to trim dental benefits. The story says expanded dental coverage reflects recognition of oral health's importance to overall health. For plans and state rate setters, any benefit rollback should flow into lower capitation trend assumptions and network revenue, not just fewer claims.
RAND: States can "weather" OBBBA's $664B Medicaid haircut
RAND published a state-by-state look at Medicaid and general-fund impacts from the One Big Beautiful Bill Act. The analysis estimates a $664 billion Medicaid funding reduction through 2034, with most states receiving fewer funds. That framing matters because it implies a larger share of the hit gets absorbed by state budgeting choices, not just eligibility math. For payers and providers, the immediate risk shifts to state actions on rates, benefits, and managed-care program funding.
BCBSMA posts $223M 2025 net loss as medical and Rx trend spikes
On Feb. 27, 2026, BCBSMA reported a 2025 net loss of $222.8M on $10.3B revenue and a $380.5M operating loss. Q4 alone was a $121.5M net loss, and management said 2025 results included a premium deficiency reserve as medical and pharmacy costs surged. Blue Cross said 90% of premiums went to medical and drug spend, so admin cuts and investment income cannot offset trend. Nationally, KFF estimates 2024 MA gross margins averaged $1,655 per enrollee, but fell 17% year over year, a warning for 2026 pricing and reserves.
GoodRx sells employers a GLP-1 buy-down outside the pharmacy benefit
On Feb. 24, 2026, GoodRx launched Employer Direct, letting employers subsidize manufacturer-sponsored cash prices for brand drugs like Wegovy. GoodRx says the employer contribution is applied automatically at the pharmacy counter, without adding the drug to the health plan formulary or benefit. The model debuted earlier in 2026 with Hy-Vee, and can be bundled with employer-branded telemedicine programs such as GoodRx for Weight Loss. For finance teams, it is a deliberate carve-out: GLP-1 affordability shifts from plan-paid Rx claims to a controllable employer subsidy layered on cash pricing.
Significant Digit
Medicaid managed care MLR remittances can turn into real federal dollars, but OIG found CMS could not readily tell if states sent the federal share back.
HHS OIG reports that 16 states told CMS their Medicaid managed care plans owed $406M in MLR remittances for the 2017-2018 and/or 2018-2019 reporting years, implying federal shares of at least $203M. As of January 2024, CMS could not readily determine whether any of those federal shares had been returned, and had to outreach to states to piece it together. If you price Medicaid MCO admin load or forecast state/federal cash flows, this is the kind of "small" control gap that becomes a big reconciliation headache.
Other Relevant Headlines
Policy & Regulation
| Health Gorilla asks court to toss Epic interoperability lawsuit | MedCity News |
| FDA uses CNPV fast lane to expand Hernexeos lung cancer use | fda.gov |
| Elevance taps Rachel Chinetti to lead 1.4M-life Wellpoint Tennessee | businesswire.com |
| CMS halts enrollment in Elevance's Medicare Advantage plans, citing years of misconduct | STAT |
| Report: Most states are investing in value-based care with the Rural Health Transformation Program | Fierce Healthcare |
| GOP lawmakers to release prior authorization crackdown legislation | Inside Health Policy |
Pharmacy & Drug Pricing
| CMS extends application deadline for new Medicaid drug pricing model | Fierce Healthcare |
| He Needs an Expensive Drug. A Copay Card Helped -- Until It Didn't. | KFF Health News |
| How PBM reforms could push drugmakers into the pricing spotlight | Healthcare Dive |
| Hospitals worry GLOBE and GUARD demos could harm 340B | Inside Health Policy |
Payer Operations
| Centene pitches CMS on 7 Medicaid fraud reforms | Becker's Payer |
| Regional Medicare Advantage plans tout record growth as competitors pull back | Becker's Payer |
ICYMI (Recent Key Stories)
- OIG flags $285M Colorado Medicaid overpayments for autism ABA therapy -- A federal audit found Colorado Medicaid may have overpaid about $285M for autism ABA therapy services. (2026-03-02)
- KFF: Enhanced ACA subsidies expiring in 2025 hit older enrollees hardest -- A KFF analysis says the scheduled end of enhanced ACA subsidies would raise costs most for older enrollees. (2026-02-27)
- CMS CY 2026 Physician Fee Schedule rule targets skin substitute pricing -- CMS proposed CY 2026 physician payment changes that would revise how skin substitute products are priced and paid. (2026-02-26)
- State lawmakers seek restraints on wage garnishment for medical debt -- Legislators in multiple states are proposing limits on using wage garnishment to collect unpaid medical bills. (2026-02-25)
- Tri-agencies extend QPA enforcement discretion to Feb. 1, 2026 -- Federal agencies extended enforcement discretion on certain QPA requirements under the No Surprises Act to Feb. 1, 2026. (2026-02-24)